Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Strensiq (asfotase alfa) for the Treatment of Hypophosphatasia

Drug (Brand / Generic)

Strensiq (asfotase alfa)

Company / Licensee

Alexion Pharmaceuticals

Current Indication

Hypophosphatasia (HPP)

Development Status

Approved in the US, Europe, Japan and Canada

Go Top